Home > Publications Database > Assessment of SLC25A46 variants in idiopathic Parkinson's disease. > print

001     282914
005     20251218105736.0
024 7 _ |a 10.1016/j.parkreldis.2025.108092
|2 doi
024 7 _ |a pmid:41385895
|2 pmid
024 7 _ |a 1353-8020
|2 ISSN
024 7 _ |a 1873-5126
|2 ISSN
037 _ _ |a DZNE-2025-01375
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Schneider, Zachary
|b 0
245 _ _ |a Assessment of SLC25A46 variants in idiopathic Parkinson's disease.
260 _ _ |a Amsterdam [u.a.]
|c 2025
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1766051780_31262
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Rare damaging variants in the SLC25A46 gene were recently reported to be associated with optic atrophy and parkinsonism in compound heterozygous state. Here, we comprehensively investigated the role of SLC25A46 variation in idiopathic Parkinson's disease (PD) by leveraging whole genome sequencing (WGS) and genotyping imputed data from the Global Parkinson's Genetics Program (GP2) and the Accelerating Medicines Partnership for Parkinson's disease initiative (AMP-PD). Our analyses included genotyping imputed data from 19,573 PD cases and 11,748 neurologically healthy controls of European, African Admixed, African, East Asian, Ashkenazi Jewish, Middle Eastern, Central Asian, and Latino and Indigenous people of the Americas ancestries from GP2. Additionally, we mined WGS data from 924 PD patients and 229 healthy controls, as well as 3359 PD cases and 4153 neurologically healthy controls of European ancestry from GP2 and AMP-PD, respectively. Burden analysis of rare non-synonymous variants across case-control individuals from WGS data did not find evidence of SLC25A46 association with PD. Of the four SLC25A46 variants observed, the p.K256R variant previously reported by Bitetto et al. was found in 1/3359 controls and 1/4153 cases of European ancestry but its association was not significant. In addition, we identified p.E79K/p.V211M in 1/3359 controls and 1/4153 cases, without confirmation of a putative compound heterozygosity effect due to the lack of phasing data. This variant was also identified in Admixed American/Latin American, African Admixed, Ashkenazi Jewish, and Central Asian ancestries. However, no significant enrichment in cases versus controls was observed. Our results do not support a major role for SLC25A46 in idiopathic PD in the European population or other ancestries, though our imputation results require cautious interpretation for ultra-rare variants.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Genetics
|2 Other
650 _ 7 |a Parkinson's disease
|2 Other
650 _ 7 |a Risk factor
|2 Other
650 _ 7 |a SLC25A46
|2 Other
700 1 _ |a Liu, Hui
|0 P:(DE-2719)9001971
|b 1
700 1 _ |a Dehestani, Mohammad
|0 P:(DE-2719)9002232
|b 2
|u dzne
700 1 _ |a Makarious, Mary B
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Crea, Peter Wild
|b 4
700 1 _ |a Bandres-Ciga, Sara
|b 5
700 1 _ |a Gasser, Thomas
|0 P:(DE-2719)2320009
|b 6
|u dzne
700 1 _ |a Kim, Jonggeol J
|0 P:(DE-HGF)0
|b 7
|e Last author
700 1 _ |a Program, Global Parkinson's Genetics
|b 8
|e Collaboration Author
773 _ _ |a 10.1016/j.parkreldis.2025.108092
|g Vol. 143, p. 108092 -
|0 PERI:(DE-600)2027635-7
|p 108092
|t Parkinsonism & related disorders
|v 143
|y 2025
|x 1353-8020
856 4 _ |u https://pub.dzne.de/record/282914/files/DZNE-2025-01375%20SUP.docx
856 4 _ |u https://pub.dzne.de/record/282914/files/DZNE-2025-01375_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/282914/files/DZNE-2025-01375_Restricted.pdf?subformat=pdfa
|x pdfa
856 4 _ |u https://pub.dzne.de/record/282914/files/DZNE-2025-01375%20SUP.doc
856 4 _ |u https://pub.dzne.de/record/282914/files/DZNE-2025-01375%20SUP.odt
856 4 _ |u https://pub.dzne.de/record/282914/files/DZNE-2025-01375%20SUP.pdf
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9001971
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)9002232
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2320009
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-07
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-07
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PARKINSONISM RELAT D : 2022
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-07
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-07
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2025-01-07
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21